Neferine enhances insulin sensitivity in insulin resistant rats

Journal of Ethnopharmacology

Volumn 124, Issue 1, 2009, Pages 98-102

  Pan, Yang ^a   Cai, Baochang ^a   Wang, Kelin ^b   Wang, Sumin ^c   Zhou, Shuyuan ^a   Yu, Xiaochun ^b   Xu, Bin ^a   Chen, Long ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Insulin resistant rat; Insulin sensitivity; Neferine; Rosiglitazone

Indexed keywords

GLUCOSE; INSULIN; NEFERINE; NELUMBO NUCIFERA EXTRACT; ROSIGLITAZONE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DRUG ACTIVITY; DRUG ISOLATION; DRUG STRUCTURE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTI-OBESITY AGENTS; BENZYLISOQUINOLINES; BLOOD GLUCOSE; FEMALE; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; NELUMBO; OBESITY; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; SEEDS; THIAZOLIDINEDIONES; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

NELUMBO NUCIFERA; RATTUS;

EID: 67349276613     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.04.008     Document Type: Article

References (33)

1. Bergman E.N., Reulein S.S., and Corlett R.E. Effects of obesity on insulin sensitivity and responsiveness in sheep. The American Journal of Physiology 257 (1989) 772-781
2. Brüning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., Klein R., Krone W., Müller-Wieland D., and Kahn C.R. Role of brain insulin receptor in control of body weight and reproduction. Science 289 (2000) 2122-2125
3. Chen Y., Fan G., Wu H., Wu Y., and Mitchell A. Separation, identification and rapid determination of liensine, isoliensinine and neferine from embryo of the seed of Nelumbo nucifera Gaertn by liquid chromatography coupled to diode array detector and tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 43 (2007) 99-104
4. Chen J., Liu J.H., Wang T., Xiao H.J., Yin C.P., and Yang J. Effects of plant extract neferine on cyclic adenosine monophosphate and cyclic guanosine monophosphate levels in rabbit corpus cavernosum in vitro. Asian Journal of Andology 10 (2008) 307-312
5. de Alvaro C., Teruel T., Hernandez R., and Lorenzo M. Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. Journal of Biological Chemistry 279 (2004) 17070-17078
6. DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology 273 (1979) 214-226
7. DeFronzo R.A., and Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14 (1991) 173-194
8. Expert Committee on the Diagnosis Classification of Diabetes Mellitus. Report of the expert committeeon the diagnosis and classification of diabetes mellitus. Diabetes Care 26 (2003) S5-S20
9. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., and Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271 (1996) 665-668
10. Kim S.H., Abbasi F., Chu J.W., McLaughlin T.L., Lamendola C., Polonsky K.S., and Reaven G.M. Rosiglitazone reduces glucose-stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individuals. Diabetes 54 (2005) 2447-2452
11. Kraegen E.W., Clark P.W., Jenkins A.B., Daley E.A., Chisholm D.J., and Storlien L.H. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40 (1991) 1397-1403
12. Levin B.E., Magnan C., Migrenne S., Chua Jr. S.C., and Dunn-Meynell A.A. F-DIO obesity-prone rat is insulin resistant before obesity onset. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 289 (2005) 704-711
13. Lim S.S., Jung Y.J., Hyun S.K., Lee Y.S., and Choi J.S. Rat lens aldose reductase inhibitory constituents of Nelumbo nucifera stamens. Phytotherapy Research 20 (2006) 825-830
14. Mukherjee P.K., Das J., Saha K., Giri S.N., Pal M., and Saha B.P. Antipyretic activity of Nelumbo nucifera rhizome extract. Indian Journal of Experimental Biology 34 (1996) 275-276
15. Mukherjee P.K., Saha K., Pal M., and Saha B.P. Effect of Nelumbo nucifera rhizome extract on blood sugar level in rats. Journal of Ethnopharmacology 58 (1997) 207-213
16. Mukherjee P.K., Saha K., Das J., Pal M., and Saha B.P. Studies on the anti-inflammatory activity of rhizomes of Nelumbo nucifera. Planta Medica 63 (1997) 367-369
17. Murphy G.J., and Holder J.C. PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer. Trends in Pharmacological Sciences 21 (2000) 469-474
18. Ohkoshi E., Miyazaki H., Shindo K., Watanabe H., Yoshida A., and Yajima H. Constituents from the leaves of Nelumbo nucifera stimulate lipolysis in the white adipose tissue of mice. Planta Medica 73 (2007) 1255-1259
19. Ono Y., Hattori E., Fukaya Y., Imai S., and Ohizumi Y. Anti-obesity effect of Nelumbo nucifera leaves extract in mice and rats. Journal of Ethnopharmacology 106 (2006) 238-244
20. Pascoe W.S., and Storlien L.H. Inducement by fat feeding of basal hyperglycemia in rats with abnormal beta-cell function. Model for study of etiology and pathogenesis of NIDDM. Diabetes 39 (1990) 226-233
21. Pascoe W.S., Jenkins A.B., Kusunoki M., and Storlien L.H. Insulin action and determinants of glycaemia in a rat model of type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35 (1992) 208-215
22. Pihlajamäki J., Gylling H., Miettinen T.A., and Laakso M. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. Journal of Lipid Research 45 (2004) 507-512
23. Qian J.Q. Cardiovascular pharmacological effects of bisbenzylisoquinoline alkaloid derivatives. Acta Pharmacologica Sinica 23 (2002) 1086-1092
24. Reed M.J., Meszaros K., Entes L.J., Claypool M.D., Pinkett J.G., Gadbois T.M., and Reaven G.M. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49 (2000) 1390-1394
25. Rosenzweig T., Braiman L., Bak A., Alt A., Kuroki T., and Sampson S.R. Differential effects of tumor necrosis factor-alpha on protein kinase C isoforms alpha and delta mediate inhibition of insulin receptor signaling. Diabetes 51 (2002) 1921-1930
26. Spiegelman B.M. Peroxisome proliferator-activated receptor gamma: a key regulator of adipogenesis and systemic insulin sensitivity. European Journal of Medical Research Journal 2 (1997) 457-464
27. Takano H., Nagai T., Asakawa M., Toyozaki T., Oka T., Komuro I., Saito T., and Masuda Y. Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes. Circulation Research 87 (2000) 596-602
28. Taniguchi A., Fukushima M., Sakai M., Miwa K., Makita T., Nagata I., Nagasaka S., Doi K., Okumura T., Fukuda A., Kishimoto H., Fukuda T., Nakaishi S., Tokuyama K., and Nakai Y. Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes Care 23 (2000) 1766-1769
29. Uysal K.T., Wiesbrock S.M., and Hotamisligil G.S. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity. Endocrinology 139 (1998) 4832-4838
30. Uysal K.T., Wiesbrock S.M., Marino M.W., and Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389 (1997) 610-614
31. Xiong Y.Q., and Zeng F.D. Effect of neferine on toxicodynamics of dichlorvos for inhibiting rabbit cholinesterase. Acta Pharmacologica Sinica 24 (2003) 332-336
32. Yang J., and Zhou K. NMR spectroscopic analysis of neferine and isoliensinine. Magnetic Resonance in Chemistry 42 (2004) 994-997
33. Zhao L., Wang X., Wu J., Jia Y., Wang W., Zhang S., and Wang J. Improved RP-HPLC method to determine neferine in dog plasma and its application to pharmacokinetics. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 857 (2007) 341-346